We should be measuring genomic bacterial load and virulence factors

Critical Care Medicine

Volumn 38, Issue 10 SUPPL., 2010, Pages

  Lisboa, Thiago ^a   Waterer, Grant ^b   Rello, Jordi ^c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Genomic bacterial load; Infection; Pathogen; Pathogenesis; Sepsis; Virulence

Indexed keywords

VIRULENCE FACTOR;

BACTERIAL GENOME; BACTERIUM IDENTIFICATION; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT RESPONSE;

EID: 78650338305     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181f2453a     Document Type: Conference Paper

References (67)

1. Gao H, Evans TW, Finney SJ: Bench-to-bedside review: Sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter? Crit Care 2008;12:212
2. Cohen J: Diagnosing sepsis: Does the microbiology matter? Crit Care 2008;12:145
3. Llewelyn MJ, Cohen J: Tracking the microbes in sepsis: Advancements in treatment bring challenges for microbial epidemiology. Clin Infect Dis 2007;44:1343-1348
4. Struelens MJ: Detection of microbial DNAe-mia: Does it matter for sepsis management? Intensive Care Med 2010;36:193-195
5. Bloos F, Hinder F, Becker K, et al: A multi-center trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med 2010;36:241-247
6. Dark PM, Dean P, Warhurst G: Bench-to-bedside review: The promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care 2009;13:217
7. Seng P, Drancourt M, Gouriet F, et al: Ongoing revolution in bacteriology: Routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009;49:543-551
8. Louie RF, Tang Z, Albertson TE, et al: Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008;36:1487-1492
9. Bauer S, Kirschning CJ, Häcker H, et al: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001;98:9237-9242
10. Cleven BE, Palka-Santini M, Gielen J, et al: Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray. J Clin Microbiol 2006;44:2389-2397
11. Peters RP, van Agtmael MA, Danner SA, et al: New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004;4:751-760
12. Reier-Nilsen T, Farstad T, Nakstad B, et al: Comparison of broad range 16S rDNA PCR and conventional blood culture for diagnosis of sepsis in the newborn: A case-control study. BMC Pediatr 2009;9:5
13. Apfalter P, Stoiser B, Barousch W, et al: Community-acquired bacteria frequently detected by means of quantitative polymerase chain reaction in nosocomial early-onset ventilator-associated pneumonia. Crit Care Med 2005;33:1492-1498
14. O'Brien TR, Blattner WA, Waters D, et al: Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-110
15. O'Brien WA, Hartigan PM, Martin D, et al: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-431
16. Rello J, Lisboa T, Lujan M, et al: Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009;136:832-840
17. Parsons HK, Metcalf SC, Tomlin K, et al: Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom. JInfect 2007;54:435-438
18. Carrol ED, Guiver M, Nkhoma S, et al: High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J 2007;26:416-422 (Pubitemid 46789323)
19. Cohen J: The immunopathogenesis of sepsis. Nature 2002;420:885-891
20. Hackett SJ, Guiver M, Marsh J, et al: Menin-gococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 2002;86:44-46
21. Lala HM, Mills GD, Barratt K, et al: Menin-gococcal disease deaths and the frequency of antibiotic administration delays. J Infect 2007;54:551-557
22. Brandtzaeg P, Bjerre A, Øvstebø R, et al: Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 2001;7:401-420
23. Darton T, Guiver M, Naylor S, et al: Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis 2009;48:587-594
24. Brandtzaeg P, Øvstebø R, Kierulf P: Quantitative detection of bacterial lipopolysaccha-rides in clinical specimens. In: Meningococ-cal Disease: Methods and Protocols. Pollard AJ (Ed). Totowa, NJ, Humana Press, 2001, pp 411-426
25. Brandtzaeg P, Høgåsen K, Kierulf P, et al: The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis 1996;173:647-655
26. Høgåsen K, Mollnes TE, Brandtzaeg P: Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin- antithrombin complex. Infect Immun 1994;62:4874-4880
27. Bjerre A, Brusletto B, Høiby EA, et al: Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit Care Med 2004;32:433-438
28. Bell LM, Alpert G, Campos JM, et al: Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia. Pediatrics 1985;76:901-904
29. Sullivan TD, LaScolea LJ Jr, Neter E: Relationship between the magnitude of bactere-mia in children and the clinical disease. Pediatrics 1982;69:699-702
30. Peralta G, Rodríguez-Lera MJ, Garrido JC, et al: Time to positivity in blood cultures of adults with Streptococcus pneumoniae bac-teremia. BMC Infect Dis 2006;6:79
31. Peters RP, de Boer RF, Schuurman T, et al: Streptococcus pneumoniae DNA load in blood as marker of infection in patients with community-acquired pneumonia. J Clin Mi-crobiol 2009;47:3308-3312
32. Carrol ED, Guiver M, Nkhoma S, et al: High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J 2007;26:416-422 (Pubitemid 46789323)
33. Peters RP, van Agtmael MA, Gierveld S, et al: Quantitative detection of Staphylococcus au-reus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J. Clin Microbiol 2007;45:3641-3646
34. Navarro E, Segura JC, Castaño MJ, et al: Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin Infect Dis 2006;42:1266-1273
35. Póvoa, P, Coelho L, et al: Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis 2005;40:1855-1857
36. Morrison DC, Bucklin SE: Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis. Scand J Infect Dis Suppl 1996;101:3-8
37. Holzheimer RG: Antibiotic induced endo-toxin release and clinical sepsis: A review. J Chemother 2001;1:159-172
38. Webb SAR, Kahler CM: Bench-to-bedside review: Bacterial virulence and subversion of host defences. Crit Care 2008;12:234
39. Garcia-Suárez MM, Vázquez F, Méndez FJ: Streptococcus pneumoniae virulence factors and their clinical impact: An update. Enferm Infecc Microbiol Clin 2006;24:512-517
40. Anderson R, Steel HC, Cockeran R, et al: Comparison of the effects of macrolides, amoxicilin, ceftriaxone, doxycycline, tobra-mycin, and fluoroquinolones on the production of pneumolysin by Streptococcus pneu-moniae in vitro. J Antibmicrob Chemother 2007;60:1155-1158
41. Gor DO, Ding X, Briles DE, et al: Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect Immun 2005;73:1304-1312
42. Berry AM, Paton JC: Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 2000;68:133-140
43. Nabors GS, Braun PA, Herrmann DJ, et al: Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 2000;18:1743-1754
44. Hausdorff WP, Feikin DR, Klugman KP: Ep-idemiological differences among pneumo-coccal serotypes. Lancet Infect Dis 2005;5:83-93
45. Gordon RJ, Lowy FD: Pathogenesis of methi-cillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008;46: S350-S359
46. Donlan RM, Costerton JW: Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-193
47. Prévost G, Couppié P, Monteil H: Staphylococcal epidermolysins. Curr Opin Infect Dis 2003;16:71-76
48. Peacock SJ, Moore CE, Justice A, et al: Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus au-reus. Infect Immun 2002;70:4987-4996
49. Hensler T, König B, Prévost G, et al: Leuko-triene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: Protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutro-phils. Infect Immun 1994;62:2529-2535
50. König B, Köller M, Prévost G, et al: Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): Generation of inter-leukin-8. Infect Immun 1994;62:4831-4837
51. Genestier AL, Michallet MC, Prévost G, et al: Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005;115:3117-3127
52. Veesenmeyer JL, Hauser AR, Lisboa T, et al: Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies. Crit Care Med 2009;37:1777-1786
53. Sadikot RT, Blackwell TS, Christman JW, et al: Pathogen-host interactions in Pseudomo-nas aeruginosa pneumonia. Am J Respir Crit Care Med 2005;171:1209-1223
54. Kipnis E, Sawa T, Wiener-Kronish J: Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect 2006;36:78-91
55. Kurahashi K, Kajikawa O, Sawa T, et al: Pathogenesis of septic shock in Pseudomo-nas aeruginosa pneumonia. J Clin Invest 1999;104:743-750
56. Lorenz E, Chemotti DC, Vandal K, et al: Toll-like receptor 2 represses nonpilus adhe-sin-induced signaling in acute infections with the Pseudomonas aeruginosa pilA mutant. Infect Immun 2004;72:4561-4569
57. Frank DW: The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol 1997;26:621-629
58. Hauser AR, Cobb E, Bodi M, et al: Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomo-nas aeruginosa. Crit Care Med 2002;30:521-528
59. Roy-Burman A, Savel RH, Racine S, et al: Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001;183:1767-1774
60. Zhuo H, Yang K, Lynch SV, et al: Increased mortality of ventilated patients with endotra-cheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med 2008;36:2495-2503
61. Høiby N, Krogh Johansen H, Moser C, et al: Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001;3:23-35.
62. Kollef MH, Afessa B, Anzueto A, et al: Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: The NASCENT randomized trial. JAMA 2008;300:805-813
63. Rello J, Kollef M, Diaz E, et al: Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med 2006;34:2766-2772
64. Montie TC, Doyle-Huntzinger D, Craven RC, et al: Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infect Immun 1982;38:1296-1298
65. Fleiszig SM, Arora SK, Van R, et al: FlhA, a component of the flagellum assembly apparatus of Pseudomonas aeruginosa, plays a role in internalization by corneal epithelial cells. Infect Immun 2001;69:4931-4937
66. Mahenthiralingam E, Campbell ME, Speert DP: Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fi-brosis. Infect Immun 1994;62:596-605
67. Döring G, Meisner C, Stern M: A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa fla-gella vaccine in cystic fibrosis patients. Proc Natl Acad Sci USA 2007;104:11020-11025